Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes
Athena Philis‐Tsimikas, Harpreet S. Bajaj, Kamilla Begtrup, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 331-341
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Investigating the Incidence of Dyslipidemia among Brazilian Children and Adolescents Diagnosed with Type 1 Diabetes Mellitus: A Cross-Sectional Study
R. F. Melo, Lucas Fornari Laurindo, Kátia Portero Sloan, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 45-45
Open Access | Times Cited: 2
Diabetes Technology Meeting 2023
Tiffany Tian, Rachel E. Aaron, Ashley Y. DuBord, et al.
Journal of Diabetes Science and Technology (2024) Vol. 18, Iss. 5, pp. 1208-1244
Open Access | Times Cited: 2
Once-Weekly Insulin Icodec in Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Clinical Trials (ONWARDS Clinical Program)
Giuseppe Lisco, Anna De Tullio, Vincenzo De Geronimo, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1852-1852
Open Access | Times Cited: 2
Cost–utility analysis and drug pricing of once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
Shanshan Hu, Shuowen Wang, Shengying Gu, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1
Richard M. Bergenstal, Björg Ásbjörnsdóttir, Sara Kehlet Watt, et al.
The Lancet Diabetes & Endocrinology (2024)
Closed Access | Times Cited: 2
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications
Ylenia Ingrasciotta, Giacomo Vitturi, Gianluca Trifirò
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2113-2113
Open Access | Times Cited: 1
Counseling for Insulin Icodec: A Proposed Practitioner’s Guide
Sanjay Kalra, Saptarshi Bhattacharya, Nitin Kapoor
Diabetes Therapy (2024) Vol. 15, Iss. 7, pp. 1491-1499
Open Access | Times Cited: 1
Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review
Julio Rosenstock, Harpreet S. Bajaj, Ildiko Lingvay, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 3, pp. e003930-e003930
Open Access | Times Cited: 1
Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
Hirotaka Watada, Björg Ásbjörnsdóttir, Tomoyuki Nishida, et al.
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 1
Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan
Yasuaki Hayashino, Satoshi Tsuboi, Yuiko Yamamoto, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 12, pp. 2537-2555
Open Access | Times Cited: 1
Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes
Ildiko Lingvay, Björg Ásbjörnsdóttir, Niels Rode Kristensen, et al.
Endocrine Practice (2024)
Open Access | Times Cited: 1
Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
Xinxin Wang, Wei Xiao, Zhanpeng Liang, et al.
Medicine (2023) Vol. 102, Iss. 52, pp. e36308-e36308
Open Access | Times Cited: 3
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Julio Rosenstock, Amoolya Gowda, Bo Liang
New England Journal of Medicine (2023) Vol. 389, Iss. 16, pp. 1532-1533
Open Access | Times Cited: 2
News in insulin treatment
Dominika Mačáková, Ondřej Krystyník, Ľubica Cibičková, et al.
Vnitřní lékařství (2024) Vol. 70, Iss. 1, pp. 49-54
Open Access
New Insulins, Biosimilars, and Insulin Therapy
Thomas Danne, Lutz Heinemann, Thomas R. Pieber
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. S1, pp. S-67
Closed Access
Traiter les hypoglycémies iatrogènes à l’ère des nouvelles technologies
L. Monnier, C Colette
Médecine des Maladies Métaboliques (2024) Vol. 18, Iss. 3, pp. 258-267
Closed Access
An update of contemporary insulin therapy
Yuan‐Yu Tsai, Yuh‐Shiou Gu, Yi‐Der Jiang
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 8, pp. 1000-1002
Open Access
What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art
Christiano Argano, Laura Priola, Francesco Manno, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 900-900
Open Access
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review
David Russell‐Jones, Timothy S. Bailey, Wendy Lane, et al.
Diabetic Medicine (2024) Vol. 41, Iss. 7
Open Access
Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients
Chrysoula Kosmeri, Maria Baltogianni, Vasileios Giapros, et al.
Endocrines (2024) Vol. 5, Iss. 2, pp. 214-224
Open Access
Advances in insulin: a review of icodec as a novel once-weekly treatment for type 2 diabetes
Javier Morales, Aaron King, Sean M. Oser, et al.
Postgraduate Medicine (2024)
Open Access
Icodec ONWARDS: A review of the first once-weekly diabetes treatment for nurse practitioners and physician assistants
Davida F. Kruger, Melissa Magwire, Scott Urquhart
Journal of the American Association of Nurse Practitioners (2024)
Open Access
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management
Jennifer D. Goldman, Curtis Triplitt, Diana Isaacs
Annals of Pharmacotherapy (2024)
Open Access
Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
Mei Xue, Pan Shen, Jun Tang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Evaluating semaglutide + LAI-287 (IcoSema) for the treatment of diabetes mellitus type II
Maka Siamashvili, Stephen N. Davis
Expert Opinion on Pharmacotherapy (2024), pp. 1-7
Closed Access

Scroll to top